Compare Unichem Lab with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ABBOTT INDIA UNICHEM LAB/
ABBOTT INDIA
 
P/E (TTM) x -44.5 48.1 - View Chart
P/BV x 1.1 15.6 7.0% View Chart
Dividend Yield % 1.3 0.4 286.6%  

Financials

 UNICHEM LAB   ABBOTT INDIA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
ABBOTT INDIA
Mar-19
UNICHEM LAB/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2928,834 3.3%   
Low Rs1825,458 3.3%   
Sales per share (Unadj.) Rs167.71,731.1 9.7%  
Earnings per share (Unadj.) Rs-3.6211.9 -1.7%  
Cash flow per share (Unadj.) Rs5.9219.9 2.7%  
Dividends per share (Unadj.) Rs4.0065.00 6.2%  
Dividend yield (eoy) %1.70.9 185.5%  
Book value per share (Unadj.) Rs372.3945.2 39.4%  
Shares outstanding (eoy) m70.3821.25 331.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.44.1 34.2%   
Avg P/E ratio x-65.333.7 -193.6%  
P/CF ratio (eoy) x39.932.5 122.7%  
Price / Book Value ratio x0.67.6 8.4%  
Dividend payout %-110.230.7 -359.2%   
Avg Mkt Cap Rs m16,680151,848 11.0%   
No. of employees `0002.63.5 74.7%   
Total wages/salary Rs m2,3934,356 54.9%   
Avg. sales/employee Rs Th4,535.210,555.5 43.0%   
Avg. wages/employee Rs Th919.81,249.9 73.6%   
Avg. net profit/employee Rs Th-98.21,292.2 -7.6%   
INCOME DATA
Net Sales Rs m11,80136,786 32.1%  
Other income Rs m9841,133 86.9%   
Total revenues Rs m12,78537,919 33.7%   
Gross profit Rs m-8356,047 -13.8%  
Depreciation Rs m674169 398.2%   
Interest Rs m7523 334.2%   
Profit before tax Rs m-6006,989 -8.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3432,485 -13.8%   
Profit after tax Rs m-2564,503 -5.7%  
Gross profit margin %-7.116.4 -43.0%  
Effective tax rate %57.335.6 161.1%   
Net profit margin %-2.212.2 -17.7%  
BALANCE SHEET DATA
Current assets Rs m20,38427,610 73.8%   
Current liabilities Rs m5,0298,569 58.7%   
Net working cap to sales %130.151.8 251.4%  
Current ratio x4.13.2 125.8%  
Inventory Days Days10560 174.0%  
Debtors Days Days13527 492.3%  
Net fixed assets Rs m9,0231,057 853.8%   
Share capital Rs m141213 66.3%   
"Free" reserves Rs m26,05819,873 131.1%   
Net worth Rs m26,19920,086 130.4%   
Long term debt Rs m00-   
Total assets Rs m31,49629,409 107.1%  
Interest coverage x-7.0311.6 -2.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.41.3 30.0%   
Return on assets %-0.615.4 -3.7%  
Return on equity %-1.022.4 -4.4%  
Return on capital %-2.034.9 -5.7%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,188369 2,219.2%   
Fx outflow Rs m5964,918 12.1%   
Net fx Rs m7,592-4,549 -166.9%   
CASH FLOW
From Operations Rs m-3,2784,991 -65.7%  
From Investments Rs m-2,860-2,570 111.3%  
From Financial Activity Rs m-24-1,428 1.7%  
Net Cashflow Rs m-4,690993 -472.2%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 15.1 7.9 191.1%  
FIIs % 3.0 0.1 3,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 17.1 185.4%  
Shareholders   20,176 18,270 110.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE SCIENCES  DR. DATSONS LABS  WOCKHARDT  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

6 Reasons Why Sensex Plunged 883 Points Today(Closing)

Indian share markets nosedived and registered sharp losses in today's volatile session following a strong second wave of Covid-19 in the country.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Apr 19, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS